Latest news
Biochar can reshape how soils respond to warming, but the effect depends on the soil
A new study shows that biochar can change how strongly soil nitrous oxide emissions respond to rising temperatures. But the effect is not one-size-fits-all. The study found that nitrous oxide emissions increased with warming in both agricultural soil and forest soil, but forest soil was more temperature-sensitive than agricultural soil.
Maternal RSV vaccine cuts infant hospitalizations by 70%
A study has found that vaccination against respiratory syncytial virus (RSV) during pregnancy reduced the risk of hospitalization in young infants by nearly 70%. It provides early real-world evidence from U.S. clinical care, showing that administering one dose of the maternal RSV vaccine (RSVpreF vaccine) reduces hospitalization related to RSV in young infants.
Flu drugs show promise against cognitive decline
A class of flu drugs may reduce cognitive decline and premature aging in people living with chronic viral infection. Scientists identified a new biological culprit: the degradation of protective sugar molecules in our bodies, known as glycans, that normally help keep inflammation in check.
Data from patients hospitalised with COVID-19 made available to the scientific community
The DIVINE study database has been published. The cohort includes clinical information from 5,813 patients hospitalised with COVID-19 during four waves of the pandemic, between March 2020 and August 2021, across five hospitals in the southern metropolitan area of Barcelona.
Researcher discovers single-celled organism that transforms into cannibalistic supergiant
Researchers have discovered a microscopic organism that can transform into a cannibalistic ’supergiant’ that drastically changes size, shape, and behavior, and abandons filter-feeding to hunt and consume their genetically identical relatives.
From spider silk to science: a new way to access hidden fungal diversity
A new study suggests that spider webs - particularly those incorporating environmental debris - can serve as natural, non-destructive collectors of fungal material in agricultural ecosystems. The findings show that viable fungi can be recovered from these structures, including lineages that may represent previously undocumented diversity.
Biochar can reshape how soils respond to warming, but the effect depends on the soil
A new study shows that biochar can change how strongly soil nitrous oxide emissions respond to rising temperatures. But the effect is not one-size-fits-all. The study found that nitrous oxide emissions increased with warming in both agricultural soil and forest soil, but forest soil was more temperature-sensitive than agricultural soil.
Maternal RSV vaccine cuts infant hospitalizations by 70%
A study has found that vaccination against respiratory syncytial virus (RSV) during pregnancy reduced the risk of hospitalization in young infants by nearly 70%. It provides early real-world evidence from U.S. clinical care, showing that administering one dose of the maternal RSV vaccine (RSVpreF vaccine) reduces hospitalization related to RSV in young infants.
Flu drugs show promise against cognitive decline
A class of flu drugs may reduce cognitive decline and premature aging in people living with chronic viral infection. Scientists identified a new biological culprit: the degradation of protective sugar molecules in our bodies, known as glycans, that normally help keep inflammation in check.
Andelyn Biosciences launches LVV Curator® Platform
Andelyn Biosciences has announced the launch of its LVV Curator® Platform, a standardized lentiviral vector (LVV) manufacturing solution built on the same proven modular approach that supports clinical and commercial adeno-associated virus (AAV) programs.
Modular Clean Air strengthens position as part of Total Clean AIr
Modular Clean Air (MCA) is now wholly owned by Total Clean Air (TCA), marking the next phase in its development following its successful launch as a joint venture in 2025.
CDI breakthroughs lead to new drug development deal for deadly NTM bacteria
Scientists have developed new compounds against non-tuberculous mycobacteria which are now the subject of a new collaboration and license agreement with the Switzerland-based and publicly listed BioVersys AG.
From spider silk to science: a new way to access hidden fungal diversity
A new study suggests that spider webs - particularly those incorporating environmental debris - can serve as natural, non-destructive collectors of fungal material in agricultural ecosystems. The findings show that viable fungi can be recovered from these structures, including lineages that may represent previously undocumented diversity.
Researchers combine bacteria and viruses to demonstrate a new way to fight cancer
Researchers have designed non-toxic Salmonella bacteria to deliver viruses that are safe to humans but potent against liver and pancreatic cancer tumors. Animal models treated with this combination of bacteria and viruses saw almost all their tumors eliminated and lived significantly longer.
New climate-based tool predicts coral bleaching months in advance
Researchers found that coral bleaching on a Caribbean island occurs when three major climate patterns in the Pacific and Atlantic Oceans align in specific ways that intensify ocean warming. They created a new, early-warning tool called the Bleaching Event Early Predictor (BEEP).
Data from patients hospitalised with COVID-19 made available to the scientific community
The DIVINE study database has been published. The cohort includes clinical information from 5,813 patients hospitalised with COVID-19 during four waves of the pandemic, between March 2020 and August 2021, across five hospitals in the southern metropolitan area of Barcelona.
Researcher studying probiotics to fight acid reflux and esophageal cancer
Patients with acid reflux, which occurs when stomach acid pushes up into the esophagus, know the symptoms all too well: heartburn, belching, chest pain and trouble swallowing. Acid reflux also increases the risk of esophageal cancer, but researchers are investigating how a simple probiotic could treat and prevent both conditions.
The future of phage therapy will be decided by more than science alone
As antimicrobial resistance accelerates worldwide, leading experts gather in Valencia to address the scientific, regulatory, manufacturing and clinical challenges that will determine whether phage therapy becomes a routine healthcare solution.